GGrantIndex
← Leaderboards

Baylor Research Institute

Dallas, TX

Compare ↔
$137,040,515
Total funding
135
Grants

Funding over time

peak $24.8M · FY2005–25
$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$119,836,115 · 121
CDC$7,810,200 · 2
AHRQ$4,910,701 · 11
DOD$4,483,499 · 1

By mechanism

R01$47,353,830 · 32
U19$46,399,166 · 45
U01$11,764,437 · 4
P50$8,118,321 · 9
R21$6,605,335 · 17
—$4,483,499 · 1

Investigators at Baylor Research Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Valerie Danesh$228,3491 gr2Anthony D. McDonald$228,3491 gr

Emerging Leaders

6–10 yrs in

1Hoa Nguyen$827,6113 gr2Jinmyoung Cho$445,2881 gr3Donald E Wesson$441,1831 gr4Kelly Rossler$89,3601 gr

All-Time

Most funded here, all years

1Tyler J. Curiel$16,002,89415 gr2Ajay Goel$11,118,3066 gr3Rhonda F Souza$5,792,8266 gr4Stuart Jon Spechler$3,593,7477 gr5Sangkon Oh$3,218,8264 gr6Giovanni Filardo$2,996,8122 gr7Zhiqiang Zhang$2,261,0002 gr8Rebecca Critchley-Thorne$1,950,2503 gr

Largest grants

Harnessing Human DC Subsets for Improved Muscosal Vaccines$5,292,047
U19 · FY2009 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,860,891
U19 · FY2009 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,812,281
U19 · FY2010 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,764,161
U19 · FY2011 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,668,879
U19 · FY2012 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$4,499,507
U19 · FY2010 · AI
DOSING OF OVERGROUND ROBOTIC GAIT TRAINING WITH FUNCTIONAL OUTCOMES AND NEUROPLASTICITY AFTER SPINAL CORD INJURY (DOOR SCI)$4,483,499
· FY2021 · Defense Health Agency
Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,362,911
U19 · FY2013 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,206,850
U19 · FY2014 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat$3,164,316
U19 · FY2004 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat$3,148,010
U19 · FY2006 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat$3,141,637
U19 · FY2008 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat$3,141,637
U19 · FY2007 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat$3,124,596
U19 · FY2005 · AI
Discretionary Funds$3,101,147
U19 · FY2013 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,077,917
U19 · FY2011 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,059,835
U19 · FY2013 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,034,833
U19 · FY2012 · AI
IMMUNITY TO MELANOMA VIA DENDRITIC CELLS$2,226,362
P01 · FY2002 · CA
IMMUNITY TO MELANOMA VIA DENDRITIC CELLS$2,194,352
P01 · FY2000 · CA